Answers are grounded in this paper and cite their sources.
Introduction Intrathecal drug delivery (IDD) provides continuous administration of analgesics into the intrathecal space. Although catheter tip placement is considered important for treatment success, evidence of its impact on long-term clinical outcomes remains limited, particularly when considering pain distribution, cancer type, and the intrathecal medication used. This systematic review and meta-analysis evaluated the evidence of catheter tip positioning in patients with refractory cancer pain.Methods PubMed, Web of Science, Scopus, and EMBASE were systematically searched from inception to October 2025. Studies including patients with refractory cancer pain treated with implanted IDD were included. Study quality was assessed using a modified Downs and Black checklist. Meta-regression was performed to evaluate associations between treatment success and catheter tip location, pain distribution, and intrathecal medication type.Results Of 8,414 identified articles, 23 studies were included (14 in meta-analysis). Catheter tip placement descriptively corresponded to cancer type and pain location. However, meta-regression analyses showed no significant association between treatment success and catheter tip location (p = 0.914), pain location (p = 0.407), or intrathecal medication category (p = 0.937).Conclusions Descriptive findings support anatomically guided catheter placement, but the available evidence is insufficient to determine whether catheter tip location or other examined factors are associated with treatment success.Protocol registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251150374 identifier is CRD420251150374.
No takes yet. Share an insight, caveat, or question.
Winnepenninckx et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: